Spyglass Pharma
Aliso Viejo
About Spyglass Pharma
Spyglass Pharma focuses on the development of novel treatments for chronic ophthalmic diseases based on technology. The company designs to deliver multiple drugs to address additional ophthalmic indications.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $184.8M
- Funding stage: Late Stage Venture
- Last round: Series D (Jun 2025)
- Website: spyglasspharma.com
- Phone: +1 949 284 6904
Industries & Categories
Delivery, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/spyglass-pharma-112444 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.